Company

Rose BioSolutions

Private

Rose BioSolutions provides cell and gene therapy contract development and manufacturing services, including plasmid DNA, viral vector, and cell therapy production along with cellular starting materials.

Rose BioSolutions is a privately held company.

www.rosebiosolutions.com ↗LinkedIn ↗

Recent developments

AI summary of recent coverage

Recent coverage of Rose BioSolutions has focused on executive leadership appointments, including the naming of David Enloe as Chief Executive Officer to lead the company's cell and gene therapy platform and Thomas VanCott as Head of HemaCare. The company has also been featured in industry roundups and analysis following its formation through GI Partners' acquisition of contract development, manufacturing, and cell solutions businesses from Charles River Laboratories.

Summarized from the headlines in the sidebar; see each source for the full story.